Spin-off news
Here you can find news from MPG spin-off companies.
Alnylam
Alnylam Presents Positive Results from ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1
MODAG
Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate
MorphoSys
First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in Patients with Immunoglobulin A Nephropathy
Alnylam
Alnylam Completes Enrollment in HELIOS-B Phase 3 Study of Investigational Vutrisiran in Patients with Transthyretin-Mediated (ATTR) Amyloidosis with Cardiomyopathy